Aclaris Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Walker Neal | Interim President and CEO | Tax Withholding | 3,223 | $1.24 | $3,997 | 1,279,445 | Mar 1, 2024 |
| Monahan Joseph | Chief Scientific Officer | Tax Withholding | 3,531 | $1.24 | $4,378 | 186,783 | Mar 1, 2024 |
| Balthaser Kevin | Chief Financial Officer | Tax Withholding | 427 | $1.24 | $529 | 23,983 | Mar 1, 2024 |
| Monahan Joseph | Chief Scientific Officer | Option Exercise | 7,500 | — | — | 137,224 | Feb 1, 2024 |
| Loerop James | Chief Business Officer | Tax Withholding | 3,853 | $1.20 | $4,624 | 29,085 | Feb 1, 2024 |
| Balthaser Kevin | Chief Financial Officer | Option Exercise | 7,500 | — | — | 22,961 | Jan 1, 2024 |
| Manion Douglas J. | Pres and CEO | Option Exercise | 27,000 | — | — | 50,938 | Jan 1, 2024 |
| Monahan Joseph | Chief Scientific Officer | Sale | 6,000 | $5.08 | $30,480 | 129,724 | Oct 23, 2023 |
| Balthaser Kevin | Chief Financial Officer | Purchase | 9,490 | $7.90 | $74,971 | 15,461 | Sep 6, 2023 |
| Balthaser Kevin | Chief Financial Officer | Option Exercise | 1,000 | — | — | 6,256 | Sep 1, 2023 |
| Loerop James | Chief Business Officer | Purchase | 14,705 | $6.80 | $99,994 | 21,688 | Aug 28, 2023 |
| Monahan Joseph | Chief Scientific Officer | Sale | 6,000 | $7.32 | $43,920 | 135,724 | Aug 21, 2023 |
| Manion Douglas J. | Pres and CEO | Tax Withholding | 4,437 | $9.81 | $43,527 | 23,938 | Aug 1, 2023 |
| Cawkwell Gail | Chief Medical Officer | Option Exercise | 15,000 | — | — | 15,000 | Jul 1, 2023 |
| Molineaux Christopher P. | — | Option Exercise | 16,500 | $1.41 | $23,265 | 48,503 | Jun 20, 2023 |
| Monahan Joseph | Chief Scientific Officer | Sale | 6,000 | $10.28 | $61,680 | 141,724 | Jun 20, 2023 |
| Molineaux Christopher P. | — | Option Exercise | 198 | $1.52 | $301 | 32,003 | Jun 15, 2023 |
| Humphries William D. | — | Option Exercise | 4,507 | — | — | 24,072 | Jun 2, 2023 |
| MILANO VINCENT | — | Option Exercise | 4,507 | — | — | 7,863 | Jun 2, 2023 |
| GOWEN MAXINE | — | Option Exercise | 4,507 | — | — | 12,301 | Jun 2, 2023 |
| Molineaux Christopher P. | — | Option Exercise | 4,507 | — | — | 31,754 | Jun 2, 2023 |
| Reasons Bryan M. | — | Option Exercise | 4,507 | — | — | 24,072 | Jun 2, 2023 |
| SCHIFF ANDREW N | — | Option Exercise | 4,507 | — | — | 4,507 | Jun 2, 2023 |
| Powell Andrew Kenneth William | — | Option Exercise | 4,507 | — | — | 14,363 | Jun 2, 2023 |
| Mehra Anand | — | Option Exercise | 4,507 | — | — | 38,704 | Jun 2, 2023 |
| Manion Douglas J. | Pres and CEO | Purchase | 6,300 | $7.86 | $49,518 | 12,800 | Mar 17, 2023 |
| Manion Douglas J. | Pres and CEO | Purchase | 6,500 | $7.74 | $50,310 | 6,500 | Mar 9, 2023 |
| Walker Neal | — | Sale | 30,240 | $12.63 | $381,931 | 1,273,202 | Mar 2, 2023 |
| Balthaser Kevin | Chief Financial Officer | Sale | 1,000 | $12.29 | $12,290 | 4,650 | Mar 2, 2023 |
| Monahan Joseph | Chief Scientific Officer | Option Exercise | 10,925 | — | — | 166,061 | Mar 1, 2023 |
| Monahan Joseph | Chief Scientific Officer | Sale | 5,000 | $13.06 | $65,300 | 91,386 | Feb 15, 2023 |
| Loerop James | Chief Business Officer | Sale | 4,267 | $13.89 | $59,269 | 6,983 | Feb 8, 2023 |
| Walker Neal | — | Sale | 25,000 | $16.75 | $418,750 | 1,180,763 | Feb 2, 2023 |
| Loerop James | Chief Business Officer | Option Exercise | 11,250 | — | — | 11,250 | Feb 1, 2023 |
| Walker Neal | — | Sale | 1,618 | $16.16 | $26,147 | 1,220,763 | Jan 4, 2023 |
| Monahan Joseph | Chief Scientific Officer | Sale | 5,000 | $15.88 | $79,400 | 96,386 | Dec 15, 2022 |
| SCHIFF ANDREW N | — | Sale | 1,371 | $17.08 | $23,417 | 434,455 | Nov 11, 2022 |
| Powell Andrew Kenneth William | — | Gift | 4,000 | — | — | 9,856 | Nov 8, 2022 |
| SCHIFF ANDREW N | — | Sale | 12,018 | $17.02 | $204,546 | 502,921 | Oct 24, 2022 |
| SCHIFF ANDREW N | — | Sale | 19,944 | $16.05 | $320,101 | 561,648 | Oct 18, 2022 |
| Monahan Joseph | Chief Scientific Officer | Sale | 5,000 | $15.98 | $79,900 | 101,386 | Oct 17, 2022 |
| SCHIFF ANDREW N | — | Sale | 7,324 | $16.16 | $118,356 | 581,592 | Oct 7, 2022 |
| SCHIFF ANDREW N | — | Sale | 7,700 | $16.01 | $123,277 | 626,755 | Oct 6, 2022 |
| SCHIFF ANDREW N | — | Sale | 19,565 | $15.14 | $296,214 | — | Jun 17, 2022 |
| SCHIFF ANDREW N | — | Option Exercise | 3,356 | — | — | 19,565 | Jun 3, 2022 |
| Reasons Bryan M. | — | Option Exercise | 3,356 | — | — | 19,565 | Jun 3, 2022 |
| Powell Andrew Kenneth William | — | Gift | 709 | — | — | 10,500 | Jun 3, 2022 |
| Molineaux Christopher P. | — | Option Exercise | 3,356 | — | — | 27,247 | Jun 3, 2022 |
| MILANO VINCENT | — | Option Exercise | 3,356 | — | — | 3,356 | Jun 3, 2022 |
| Mehra Anand | — | Option Exercise | 3,356 | — | — | 34,197 | Jun 3, 2022 |